150 related articles for article (PubMed ID: 8094598)
1. Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1.
Kreipe H; Alm P; Olsson H; Hauberg M; Fischer L; Parwaresch R
Am J Pathol; 1993 Feb; 142(2):651-7. PubMed ID: 8094598
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
4. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Salvesen HB; Iversen OE; Akslen LA
Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
[TBL] [Abstract][Full Text] [Related]
5. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen.
Kreipe H; Wacker HH; Heidebrecht HJ; Haas K; Hauberg M; Tiemann M; Parwaresch R
Am J Pathol; 1993 Jun; 142(6):1689-94. PubMed ID: 7685150
[TBL] [Abstract][Full Text] [Related]
6. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
[TBL] [Abstract][Full Text] [Related]
7. Ki-S1--a prognostic marker for hypopharyngeal carcinoma with potential predictive value for response to chemotherapy.
Kuropkat C; Rudolph P; Parwaresch R; Werner JA
Anticancer Res; 2003; 23(5A):3965-70. PubMed ID: 14666704
[TBL] [Abstract][Full Text] [Related]
8. Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma.
Bevilacqua P; Verderio P; Barbareschi M; Bonoldi E; Boracchi P; Dalla Palma P; Gasparini G
Breast Cancer Res Treat; 1996; 37(2):123-33. PubMed ID: 8750580
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
Markiewski M; Domagała W
Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining.
Aaltomaa S; Lipponen P; Syrjänen K
Anticancer Res; 1992; 12(4):1281-6. PubMed ID: 1380227
[TBL] [Abstract][Full Text] [Related]
11. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
Lundin J; Nordling S; von Boguslawsky K; Roberts PJ; Haglund C
Anticancer Res; 1995; 15(6B):2659-68. PubMed ID: 8669843
[TBL] [Abstract][Full Text] [Related]
13. Determination of growth fraction index in mammary carcinoma using MIB-1 monoclonal antibody: estimation of whole tumor proliferative potential using biopsy specimens.
Oda K; Yokoi S; Kanda H; Shibuya M; Kamiya S; Horisawa M; Niinomi N; Suzuki M; Hayakawa S; Kishikawa S
Tokai J Exp Clin Med; 1995 Jul; 20(2):81-8. PubMed ID: 8797264
[TBL] [Abstract][Full Text] [Related]
14. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
Narita T; Funahashi H; Satoh Y; Takagi H
Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
16. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
17. Ki-S1 and PCNA expression in erythroid precursors and megakaryocytes--a comparative study on proliferative and endoreduplicative activity in reactive and neoplastic bone marrow lesions.
Thiele J; Bertsch HP; Kracht LW; Anwander T; Zimmer JD; Kreipe H; Fischer R
J Pathol; 1994 May; 173(1):5-12. PubMed ID: 7523642
[TBL] [Abstract][Full Text] [Related]
18. A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1.
Kreipe H; Heidebrecht HJ; Hansen S; Röhlk W; Kubbies M; Wacker HH; Tiemann M; Radzun HJ; Parwaresch R
Am J Pathol; 1993 Jan; 142(1):3-9. PubMed ID: 8093827
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue.
Dervan PA; Magee HM; Buckley C; Carney DN
Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S21-8. PubMed ID: 1349455
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein.
Domagala W; Markiewski M; Harezga B; Dukowicz A; Osborn M
Clin Cancer Res; 1996 Jan; 2(1):147-54. PubMed ID: 9816101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]